245 related articles for article (PubMed ID: 2886350)
1. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
Schmauss C
Eur J Pharmacol; 1987 Jun; 137(2-3):197-205. PubMed ID: 2886350
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
Knox RJ; Dickenson AH
Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
[TBL] [Abstract][Full Text] [Related]
3. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
Bhargava HN; Ramarao P; Gulati A
Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
[TBL] [Abstract][Full Text] [Related]
4. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
Dong XW; Parsons CG; Headley PM
Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
[TBL] [Abstract][Full Text] [Related]
6. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads.
Jackson A; Cooper SJ
Brain Res Bull; 1985 Oct; 15(4):391-6. PubMed ID: 2998563
[TBL] [Abstract][Full Text] [Related]
7. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
Cooper SJ; Jackson A; Kirkham TC
Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
[TBL] [Abstract][Full Text] [Related]
8. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
11. Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the rat.
Cooper SJ; Moores WR; Jackson A; Barber DJ
Neuropharmacology; 1985 Sep; 24(9):877-83. PubMed ID: 2997653
[TBL] [Abstract][Full Text] [Related]
12. Kappa opioid agonists and antagonists: effects on drinking and urinary output.
Leander JD
Appetite; 1984 Mar; 5(1):7-14. PubMed ID: 6091543
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
14. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
16. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
Hirning LD; Porreca F; Burks TF
Eur J Pharmacol; 1985 Feb; 109(1):49-54. PubMed ID: 2986990
[TBL] [Abstract][Full Text] [Related]
17. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
18. Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat.
Jackson A; Cooper SJ
Psychopharmacology (Berl); 1988; 94(2):248-53. PubMed ID: 2895484
[TBL] [Abstract][Full Text] [Related]
19. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
Locke KW; Gorney B; Cornfeldt M; Fielding S
Psychopharmacology (Berl); 1989; 99(4):492-6. PubMed ID: 2556726
[TBL] [Abstract][Full Text] [Related]
20. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
Parsons CG; West DC; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
